Anti-SCG2/ CHGC/ EM66 functional antibody

Anti-SCG2/ CHGC/ EM66 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to SCG2/SCG2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0454-Ab-1/ GM-Tg-hg-SE0454-Ab-2Anti-Human SCG2 monoclonal antibodyHuman
GM-Tg-rg-SE0454-Ab-1/ GM-Tg-rg-SE0454-Ab-2Anti-Rat SCG2 monoclonal antibodyRat
GM-Tg-mg-SE0454-Ab-1/ GM-Tg-mg-SE0454-Ab-2Anti-Mouse SCG2 monoclonal antibodyMouse
GM-Tg-cynog-SE0454-Ab-1/ GM-Tg-cynog-SE0454-Ab-2Anti-Cynomolgus/ Rhesus macaque SCG2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0454-Ab-1/ GM-Tg-felg-SE0454-Ab-2Anti-Feline SCG2 monoclonal antibodyFeline
GM-Tg-cang-SE0454-Ab-1/ GM-Tg-cang-SE0454-Ab-2Anti-Canine SCG2 monoclonal antibodyCanine
GM-Tg-bovg-SE0454-Ab-1/ GM-Tg-bovg-SE0454-Ab-2Anti-Bovine SCG2 monoclonal antibodyBovine
GM-Tg-equg-SE0454-Ab-1/ GM-Tg-equg-SE0454-Ab-2Anti-Equine SCG2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0454-Ab-1/ GM-Tg-hg-SE0454-Ab-2; GM-Tg-rg-SE0454-Ab-1/ GM-Tg-rg-SE0454-Ab-2;
GM-Tg-mg-SE0454-Ab-1/ GM-Tg-mg-SE0454-Ab-2; GM-Tg-cynog-SE0454-Ab-1/ GM-Tg-cynog-SE0454-Ab-2;
GM-Tg-felg-SE0454-Ab-1/ GM-Tg-felg-SE0454-Ab-2; GM-Tg-cang-SE0454-Ab-1/ GM-Tg-cang-SE0454-Ab-2;
GM-Tg-bovg-SE0454-Ab-1/ GM-Tg-bovg-SE0454-Ab-2; GM-Tg-equg-SE0454-Ab-1/ GM-Tg-equg-SE0454-Ab-2
Products NameAnti-SCG2 monoclonal antibody
Formatmab
Target NameSCG2
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SCG2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0454-Ag-1Recombinant multi-species SCG2/ CHGC/ EM66 protein


    Target information

    Target IDGM-SE0454
    Target NameSCG2
    Gene ID7857,20254,24765,706499,488550,677876,281477,100061099
    Gene Symbol and SynonymsChcg,CHGC,EM66,SCG2,SgII,SN
    Uniprot AccessionP13521,P10362,P20616
    Uniprot Entry NameSCG2_HUMAN,SCG2_RAT,SCG2_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000171951
    Target ClassificationN/A

    The target: SCG2, gene name: SCG2, also named as CHGC, EM66, SN, SgII. The protein encoded by this gene is a member of the chromogranin/secretogranin family of neuroendocrine secretory proteins. Studies in rodents suggest that the full-length protein, secretogranin II, is involved in the packaging or sorting of peptide hormones and neuropeptides into secretory vesicles. The full-length protein is cleaved to produce the active peptide secretoneurin, which exerts chemotaxic effects on specific cell types, and EM66, whose function is unknown. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.